Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Can colorectal cancer mass-screening organization be evidence-based? Lessons from failures: the experimental and pilot phases of the Lazio program.
Federici A, Barca A, Baiocchi D, Quadrino F, Valle S, Borgia P, Guasticchi G, Giorgi Rossi P; Colon-Rectal Cancer Screening Working Group. Federici A, et al. Among authors: quadrino f. BMC Public Health. 2008 Sep 19;8:318. doi: 10.1186/1471-2458-8-318. BMC Public Health. 2008. PMID: 18803810 Free PMC article.
A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomised controlled trial in population-based screening programmes.
Zorzi M, Giorgi Rossi P, Cogo C, Falcini F, Giorgi D, Grazzini G, Mariotti L, Matarese V, Soppelsa F, Senore C, Ferro A; PARC Working Group. Zorzi M, et al. Prev Med. 2014 Aug;65:70-6. doi: 10.1016/j.ypmed.2014.04.022. Epub 2014 May 6. Prev Med. 2014. PMID: 24811759 Clinical Trial.
Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, Fasoli R, Di Furia L, Di Giulio E, Mantellini P, Naldoni C, Sassatelli R, Rex D, Hassan C, Zappa M; Equipe Working Group. Zorzi M, et al. Gut. 2015 Sep;64(9):1389-96. doi: 10.1136/gutjnl-2014-307954. Epub 2014 Sep 16. Gut. 2015. PMID: 25227521
Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter.
Senore C, Ederle A, DePretis G, Magnani C, Canuti D, Deandrea S, Zorzi M, Barca A, Bestagini P, Faitini K, Bisanti L, Casale C, Ferro A, GiorgiRossi P, Quadrino F, Fiorina G, Capuano A, Segnan N, Fantin A. Senore C, et al. Among authors: quadrino f. Prev Med. 2015 Apr;73:106-11. doi: 10.1016/j.ypmed.2015.01.005. Epub 2015 Jan 17. Prev Med. 2015. PMID: 25602908 Clinical Trial.
Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, de Pretis G, Di Furia L, Di Giulio E, Mantellini P, Naldoni C, Sassatelli R, Rex DK, Zappa M, Hassan C; Equipe Working Group. Zorzi M, et al. Gut. 2017 Jul;66(7):1233-1240. doi: 10.1136/gutjnl-2015-310587. Epub 2016 Feb 19. Gut. 2017. PMID: 26896459
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population.
Benevolo M, Mancuso P, Allia E, Gustinucci D, Bulletti S, Cesarini E, Carozzi FM, Confortini M, Bisanzi S, Rubino T, Rollo F, Marchi N, Farruggio A, Pusiol T, Venturelli F, Giorgi Rossi P; New Technologies for Cervical Cancer 2 (NTCC2) Working Group. Benevolo M, et al. Cancer Cytopathol. 2021 May;129(5):383-393. doi: 10.1002/cncy.22385. Epub 2020 Nov 3. Cancer Cytopathol. 2021. PMID: 33142029 Free article.
Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study.
Benevolo M, Ronco G, Mancuso P, Carozzi F, De Marco L, Allia E, Bisanzi S, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Viti J, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Bonvicini L, Venturelli F, Wentzensen N, Giorgi Rossi P; NTCC2 Working Group. Benevolo M, et al. EBioMedicine. 2024 Jun;104:105149. doi: 10.1016/j.ebiom.2024.105149. Epub 2024 May 17. EBioMedicine. 2024. PMID: 38759278 Free PMC article.
Extended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2 study.
De Marco L, Bisanzi S, Ronco G, Mancuso P, Carozzi F, Allia E, Rizzolo R, Gustinucci D, Frayle H, Viti J, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Venturelli F, Del Mistro A, Giorgi Rossi P, Benevolo M; NTCC2 Working Group. De Marco L, et al. Microbiol Spectr. 2025 Jan 7;13(1):e0089724. doi: 10.1128/spectrum.00897-24. Epub 2024 Nov 22. Microbiol Spectr. 2025. PMID: 39576120 Free PMC article.